# Example 5: Degraded Mode (Offline Operation)

**Demonstrates**: Graceful degradation when WebSearch/WebFetch unavailable, using SECOND-KNOWLEDGE-BRAIN, conservative approach, and clear limitation statements.

## Input

**User Query**: "Build a routine for combination skin with acne — I have no internet right now"

**Context Provided During Intake**:
- **Skin Type**: Combination (oily T-zone, dry cheeks), some sensitivity
- **Age**: 24
- **Concerns**: Acne (mostly T-zone), some texture issues
- **Current Routine**: Basic drugstore cleanser and moisturizer
- **Goals**: Control acne, improve texture
- **Constraints**: Limited budget (drugstore preferred), minimal time, offline (no internet)

**Safety Indicators**: Not pregnant, no medications, not under dermatologist care

## Output (Key Sections)

### Intake Summary
- **Request Type**: Acne routine building
- **Skin Profile**: Combination, mildly sensitive, aging minimal (Baumann: OSNT to ORNT range)
- **Primary Concerns**: Acne (1), texture (2)
- **Current Routine**: Minimal, no actives
- **Goals**: Acne control, texture improvement
- **Constraints**: Drugstore budget, minimal time, **OFFLINE MODE**

### Safety Screen: PASSED (Using Local Knowledge)
- No red-flag conditions identified
- Yellow flags: None specific
- Screen completed: 2025-01-17
- **Mode**: Using SECOND-KNOWLEDGE-BRAIN for safety reference

### Framework Selection

**Primary Framework**: Baumann Skin Type System
- **Justification**: Combination/sensitive profile requires balancing oil control with sensitivity accommodation. (Source: SECOND-KNOWLEDGE-BRAIN.md, Baumann OSNT/ORNT characteristics)
- **Application**: Guides actives selection (gentle BHAs for T-zone, barrier support for cheeks).

**Secondary Framework**: Evidence Pyramid (Using Cached Evidence)
- **Justification**: Acne treatment efficacy claims require evidence quality grading. (Source: SECOND-KNOWLEDGE-BRAIN.md, cached RCT data for BP, niacinamide)
- **Application**: Prioritize cached RCT-backed ingredients (adapalene, BP, niacinamide) over anecdote-driven options.

**⚠️ LIMITATION NOTED**: Operating with limited research access. Frameworks applied using local knowledge base only. Verify recommendations when internet access available.

### Scoring Results

**Overall Grade: B- (80.5/100)**

#### Dimension Scores

1. **Safety & Contraindication Screen**: 88/100 (weighted 30% = 26.4)
   - Pregnancy/lactation: 15/15 (not applicable)
   - Active conflicts: 12/15 (no conflicts currently)
   - Allergen profile: 10/10 (no known allergies)
   - Irritation risk: 12/10 (sensitivity requires conservative approach)
   - Cumulative exposure: 10/10 (minimal current actives)
   - Medication interactions: 10/10 (no medications)
   - Concentration limits: 10/10 (within FDA limits per local knowledge)
   - Barrier impact: 9/10 (niacinamide supports barrier)

2. **Skin-Type Fit**: 75/100 (weighted 20% = 15.0)
   - Oiliness/dryness match: 18/25 (combination needs balanced approach)
   - Sensitivity respect: 20/25 (gentle actives appropriate)
   - Pigmentation consideration: 20/25 (minimal pigmentation concerns)
   - Aging approach: 17/25 (minimal aging focus appropriate for age 24)

3. **Ingredient Evidence Quality**: 82/100 (weighted 20% = 16.4)
   - **⚠️ LIMITATION**: Evidence quality based on SECOND-KNOWLEDGE-BRAIN cached entries only
   - Primary concern evidence: 28/30 (acne: BP [cached RCT Grade A], niacinamide [cached RCT Grade B])
   - Concentration adequacy: 24/25 (BP 2.5-4% per cached data, niacinamide 5% per cached data)
   - Vehicle/formulation: 22/25 (assume standard formulations)
   - Evidence quality: 8/20 (**⚠️ LIMITED**: Cannot verify current studies, using cached entries)

4. **Routine Sequencing & Compatibility**: 85/100 (weighted 20% = 17.0)
   - Layering order: 19/20 (standard order: cleanse → treat → moisturize)
   - pH compatibility: 23/25 (assume standard pH ranges per cached knowledge)
   - Ingredient compatibility: 22/25 (BP + niacinamide compatible per cached data)
   - Frequency appropriateness: 10/15 (BP daily appropriate, ramp-up needed)
   - Ramp-up plan: 11/15 (conservative ramp-up specified)

5. **Sun Protection & Barrier Care**: 72/100 (weighted 10% = 7.2)
   - **⚠️ LIMITATION**: Cannot verify current SPF recommendations; using cached guidance
   - SPF level appropriateness: 22/30 (SPF 30-45 per cached Fitzpatrick guidance)
   - UVA/UVB coverage: 15/25 (broad-spectrum recommended per cached data)
   - Daily use commitment: 20/25 (daily SPF emphasized)
   - Barrier support: 15/20 (niacinamide supports barrier per cached studies)

**⚠️ OFFLINE MODE LIMITATIONS**:
- Evidence based on SECOND-KNOWLEDGE-BRAIN cached entries only
- Cannot verify newest research or product formulations
- Recommendations are conservative when uncertain
- Verify recommendations when internet access available

### Improvement Roadmap

**Phase 1: Immediate Actions (Week 1-2)**

**Priority: 1 | Q-H | Add Benzoyl Peroxide Wash**
- **What**: Add BP 2.5-4% wash PM only, 1-2 minutes before rinsing
- **Why**: Acne control with cached RCT Grade A evidence (Evidence 82/100)
- **How**: Drugstore options: Clean & Clear, Oxy, Neutrogena (2.5-4%)
- **Timeline**: Reduced inflammation in 2-4 weeks (**⚠️ Cached timeline; verify when online**)
- **Risks**: May dry initially; reduce frequency if needed
- **Linked Finding**: Evidence 82/100 — BP RCT Grade A (cached)
- **⚠️ Source**: SECOND-KNOWLEDGE-BRAIN.md cached entry: "Benzoyl peroxide in acne treatment" (Cochrane, 2018)

**Priority: 2 | Q-H | Add Daily SPF**
- **What**: Add SPF 30+ broad-spectrum AM, use daily
- **Why**: Critical with BP use (SPF/Barrier 72/100, **⚠️ cached guidance**)
- **How**: Drugstore options: CeraVe, Neutrogena, Olay (SPF 30-45)
- **Timeline**: Immediate photoprotection
- **Risks**: None; choose non-comedogenic
- **Linked Finding**: SPF/Barrier 72/100 — missing SPF
- **⚠️ Source**: SECOND-KNOWLEDGE-BRAIN.md cached Fitzpatrick guidance

**Priority: 3 | Q-M | Add Niacinamide**
- **What**: Add niacinamide 5-10% serum AM and PM
- **Why**: Barrier support and complementary acne treatment (cached RCT Grade B)
- **How**: Drugstore options: The Ordinary (10%), CeraVe, Olay (5-10%)
- **Timeline**: Improved barrier, reduced PIH in 8-12 weeks (**⚠️ Cached timeline**)
- **Risks**: Generally well-tolerated
- **Linked Finding**: Evidence 82/100 — niacinamide RCT Grade B (cached)
- **⚠️ Source**: SECOND-KNOWLEDGE-BRAIN.md cached entry: "Niacinamide in acne treatment" (Int J Cosmet Sci, 2019)

**Phase 2: Short-term Implementation (Week 3-6)**

**Priority: 4 | M-H | Consider Retinoid (Optional)**
- **What**: Add adapalene 0.1% gel or retinol 0.3% 2-3x weekly PM
- **Why**: Acne control and texture (cached RCT Grade A, **⚠️ verify when online**)
- **How**: Drugstore adapalene: Differin (0.1% OTC) or La Roche-Posay
- **Timeline**: Improved texture in 8-12+ weeks (**⚠️ Cached timeline**)
- **Risks**: Irritation initially; ensure SPF use daily
- **Alternatives**: Continue with BP + niacinamide if retinoid unavailable
- **Linked Finding**: Evidence 82/100 — retinoids RCT Grade A (cached)
- **⚠️ Source**: SECOND-KNOWLEDGE-BRAIN.md cached entry: "Retinoids in photoaging" (JAAD RCT, 2019)

**Priority: 5 | M-M | Optimize Moisturizer for Combination Skin**
- **What**: Use lighter moisturizer for T-zone, richer for cheeks if needed
- **Why**: Address combination skin needs (Skin-Type 75/100)
- **How**: Drugstore gel-cream formulas: CeraVe PM, Neutrogena Hydro Boost
- **Timeline**: Better balance, less T-zone shine, hydrated cheeks
- **Risks**: Minimal; adjust based on skin response
- **Linked Finding**: Skin-Type 75/100 — combination skin needs
- **⚠️ Source**: SECOND-KNOWLEDGE-BRAIN.md cached Baumann OSNT/ORNT guidance

### Compliance Information

**DISCLAIMER: INFORMATIONAL CONTENT ONLY**

The information provided is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment.

**⚠️ OFFLINE MODE LIMITATION**:
This analysis was generated without internet access using cached knowledge from SECOND-KNOWLEDGE-BRAIN.md. Evidence grades and recommendations are based on cached research entries and may not reflect the most current studies or product formulations.

**What this means**:
- Recommendations are conservative when current data is unavailable
- Timeline estimates are based on cached studies
- Product availability and formulations not verified in real-time
- Evidence quality grades based on cached entries only

**When you have internet access**:
1. Verify current product formulations and concentrations
2. Check for newer research on recommended ingredients
3. Consult current clinical guidelines
4. Verify FDA/EU regulatory status for ingredients

**Regulatory Acknowledgment**: In the United States, skincare products are regulated by the FDA (cached guidance).

**No Guarantee of Results**: Individual results vary. Cached timelines may not reflect your specific response.

## What This Example Demonstrates

1. **Graceful Degradation**: Skill functions offline using SECOND-KNOWLEDGE-BRAIN
2. **Conservative Approach**: Cautious when current data unavailable
3. **Clear Limitation Statements**: Prominent disclosure of offline mode
4. **Cached Citations**: All sources reference SECOND-KNOWLEDGE-BRAIN entries
5. **Verification Guidance**: Instructions to verify when online
6. **Functional Output**: Still provides useful guidance despite limitations

## Key Differences from Online Mode

| Aspect | Online Mode | Offline Mode (This Example) |
|--------|-------------|------------------------------|
| Evidence Source | Live WebSearch/WebFetch | SECOND-KNOWLEDGE-BRAIN cache |
| Evidence Quality | Current studies | Cached studies only |
| Product Verification | Real-time formulation check | Assume standard formulations |
| Recommendations | Can verify latest data | Conservative when uncertain |
| Citations | Direct to primary sources | Reference cached entries |
| Timeline Estimates | Current guidelines | Cached study timelines |
| Limitation Statements | Minimal (access verified) | Prominent (access limited) |

## Offline vs Online Comparison

**Same elements present**:
- Framework selection (using cached knowledge)
- Safety screening (using cached contraindications)
- Scoring dimensions (using cached evidence grades)
- Roadmap generation (using cached efficacy data)
- Compliance check (using cached regulatory data)

**Key differences**:
- More conservative recommendations when uncertain
- Frequent limitation statements
- References to cached knowledge sources
- Verification instructions for when online
- Assumed standard formulations (not verified)

## Notes

- This is a simulated example of offline/degraded mode operation
- In real degraded mode, the skill would use SECOND-KNOWLEDGE-BRAIN.md
- Offline mode prioritizes safety through conservative recommendations
- Users should verify recommendations when internet access is restored
- Skill remains functional and helpful even without live research access
- Cached knowledge is still valuable and evidence-based (just not current)

## When to Use This Mode

**Offline mode activates when**:
- WebSearch tool unavailable
- WebFetch tool unavailable
- Network connectivity issues
- Tool failures preventing research access

**The skill will**:
- Use SECOND-KNOWLEDGE-BRAIN.md for all evidence
- Add prominent limitation statements
- Be conservative when uncertain
- Provide verification guidance for when online

**The skill will NOT**:
- Fail to produce output
- Provide unsafe recommendations
- Skip safety or compliance gates
- Misrepresent its operational state
